SCHEMBL25322463

SCHEMBL25322463

COCOc1c(CCO)c(OC)cc2c1CN(CCc1ccc(F)cc1)C2=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 5/20 0.47
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ KCNH2 Q12809 2/20 0.36
▸ TMEM97 Q5BJF2 2/20 0.36
▸ SIGMAR1 Q99720 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ABCB1 P08183 1/20 0.36
▸ HTR2A P28223 2/20 0.35
▸ GRM2 Q14416 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TRPC5 Q9UL62 1/20 0.35
▸ PARK7 Q99497 1/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ ADRA2A P08913 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ ADRA2C P18825 1/20 0.34
▸ DRD1 P21728 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25327069 0.91 CNR2 (0.48) CNR2MEN1KMT2ASIGMAR1ABCB1
SCHEMBL25325057 0.90 CNR2 (0.45) CNR2MEN1KMT2A
SCHEMBL26579413 0.90 CNR2 (0.42) CNR2MEN1KMT2AL3MBTL1ALDH1A1
SCHEMBL24305865 0.86 CNR2 (0.48) CNR2MEN1KMT2AKCNH2TMEM97
SCHEMBL26579426 0.82 CNR2 (0.44) CNR2MEN1KMT2ASIGMAR1ALDH1A1
SCHEMBL26579397 0.82 CNR2 (0.43) CNR2MEN1KMT2AALDH1A1MAPT
SCHEMBL29662859 0.81 ABCB1 (0.48) KMT2AKCNH2TMEM97SIGMAR1ABCB1
SCHEMBL26579419 0.80 CNR2 (0.40) CNR2HRH1
SCHEMBL26579410 0.79 CNR2 (0.41) CNR2MEN1KMT2AL3MBTL1ABCB1
SCHEMBL25904794 0.77 CNR2 (0.46) CNR2MEN1KMT2AL3MBTL1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331672-A1 6-METHOXY-2-PHENETHYL ISOINDOLINE-1-ONE DERIVATIVE AND COMPOSITION FOR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME CNG BIO CO., LTD. (KR) 2023-10-19 — — US disclosed
EP-4219450-A1 6-METHOXY-2-PHENETHYL ISOINDOLINE-1-ONE DERIVATIVE AND COMPOSITION FOR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME CNG Bio Co., Ltd. (KR) 2023-08-02 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230331672-A1 6-METHOXY-2-PHENETHYL ISOINDOLINE-1-ONE DERIVATIVE AND COMPOSITION FOR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME NGF, BDNF, NTRK2 CNR2 412/4885MEN1 1336/4885KMT2A 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback